Sherwin-Williams (NYSE:SHW) Stock Rating Upgraded by StockNews.com

Sherwin-Williams (NYSE:SHW) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday.

A number of other equities research analysts have also commented on the stock. Royal Bank of Canada restated an “outperform” rating and set a $418.00 price objective on shares of Sherwin-Williams in a report on Friday, August 30th. Redburn Atlantic raised Sherwin-Williams to a “strong-buy” rating in a research note on Thursday, July 18th. Morgan Stanley upped their price objective on Sherwin-Williams from $338.00 to $375.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 24th. Barclays increased their price objective on Sherwin-Williams from $315.00 to $355.00 and gave the stock an “equal weight” rating in a report on Wednesday, July 24th. Finally, Wells Fargo & Company boosted their target price on Sherwin-Williams from $320.00 to $350.00 and gave the company an “equal weight” rating in a research note on Wednesday, July 24th. One analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $362.68.

Sherwin-Williams Stock Performance

SHW stock opened at $378.52 on Friday. Sherwin-Williams has a 1-year low of $232.06 and a 1-year high of $382.83. The company has a current ratio of 0.81, a quick ratio of 0.50 and a debt-to-equity ratio of 2.17. The firm has a market cap of $95.97 billion, a PE ratio of 40.35, a P/E/G ratio of 2.98 and a beta of 1.17. The business’s 50-day moving average price is $353.82 and its two-hundred day moving average price is $328.28.

Sherwin-Williams (NYSE:SHW) last issued its quarterly earnings data on Tuesday, July 23rd. The specialty chemicals company reported $3.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.51 by $0.19. The business had revenue of $6.27 billion during the quarter, compared to analyst estimates of $6.33 billion. Sherwin-Williams had a return on equity of 75.58% and a net margin of 10.92%. Sherwin-Williams’s quarterly revenue was up .5% compared to the same quarter last year. During the same period in the previous year, the firm earned $3.29 EPS. As a group, research analysts forecast that Sherwin-Williams will post 11.47 earnings per share for the current year.

Insider Activity

In other Sherwin-Williams news, CFO Allen J. Mistysyn sold 14,520 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $366.83, for a total value of $5,326,371.60. Following the sale, the chief financial officer now owns 63,520 shares in the company, valued at $23,301,041.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.60% of the stock is owned by insiders.

Hedge Funds Weigh In On Sherwin-Williams

Institutional investors and hedge funds have recently modified their holdings of the stock. Waterloo Capital L.P. acquired a new position in Sherwin-Williams in the 4th quarter valued at about $360,000. Valeo Financial Advisors LLC grew its position in shares of Sherwin-Williams by 7.9% in the second quarter. Valeo Financial Advisors LLC now owns 2,636 shares of the specialty chemicals company’s stock valued at $787,000 after purchasing an additional 193 shares during the last quarter. Massmutual Trust Co. FSB ADV increased its stake in shares of Sherwin-Williams by 7.2% during the first quarter. Massmutual Trust Co. FSB ADV now owns 1,533 shares of the specialty chemicals company’s stock worth $532,000 after purchasing an additional 103 shares during the period. Brevan Howard Capital Management LP lifted its holdings in Sherwin-Williams by 259.1% during the 4th quarter. Brevan Howard Capital Management LP now owns 6,998 shares of the specialty chemicals company’s stock worth $2,183,000 after purchasing an additional 5,049 shares during the last quarter. Finally, Transcend Capital Advisors LLC boosted its stake in Sherwin-Williams by 24.1% in the 2nd quarter. Transcend Capital Advisors LLC now owns 7,805 shares of the specialty chemicals company’s stock valued at $2,329,000 after purchasing an additional 1,514 shares during the period. 77.67% of the stock is currently owned by institutional investors and hedge funds.

Sherwin-Williams Company Profile

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.